|
|
???tair.name??? >
???browser.page.title.author???
|
"tsou hh"???jsp.browse.items-by-author.description???
Showing items 36-60 of 109 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2018-08-21 |
Design and data analysis of multiregional clinical trials (MRCTs)—Theory and practice
|
Chen, CT;Tsou, HH;Liu, JT;Hsiao, CF;Chen, F;Li, G;Lan, KKG |
| 國家衛生研究院 |
2018-07-27 |
GRK5 is associated with the regulation of methadone dosage in heroin dependence
|
Wang, SC;Chung, RH;Kuo, HW;Liu, TH;Fang, CP;Liu, SC;Liu, CC;Tsou, HH;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2018-03-15 |
Quantification of HBV core antibodies may help predict HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Yuan, Q;Xia, N;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C; Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2018-02-01 |
Inflammatory chemokine eotaxin-1 is correlated with age in heroin dependent patients under methadone maintenance therapy
|
Kuo, HW;Liu, TH;Tsou, HH;Hsu, YT;Wang, SC;Fang, CP;Liu, CC;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2017-11-16 |
Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine
|
Liu, TH;Chung, RH;Wang, SC;Fang, CP;Tsou, HH;Shih, CL;Kuo, HW;Wang, Y;Liu, YL |
| 國家衛生研究院 |
2017-11 |
Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration
|
Chen, YR;Chou, HC;Yang, CH;Chen, HY;Liu, YW;Lin, TY;Yeh, CL;Chao, WT;Tsou, HH;Chuang, HC;Tan, TH |
| 國家衛生研究院 |
2017-09 |
A tolerance interval approach to assessing the biosimilarity of follow-on biologics
|
Chen, CT;Tsou, HH;Hsiao, CF;Lai, YH;Chang, WJ;Liu, JT |
| 國家衛生研究院 |
2017-03-30 |
Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome
|
Kuo, HW;Shih, CL;Tsung, JH;Liu, SW;Chu, SK;Yang, HC;Tsou, HH;Wang, ZH;Chen, AC;Liu, YL |
| 國家衛生研究院 |
2017-02 |
Integrated care for geriatric frailty and sarcopenia: A randomized control trial
|
Chan, DCD;Tsou, HH;Chang, CB;Yang, RS;Tsauo, JY;Chen, CY;Hsiao, CF;Hsu, YT;Chen, CH;Chang, SF;Hsiung, CA;Kuo, KN |
| 國家衛生研究院 |
2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2017 |
Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C;Group, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2016-11-11 |
Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials
|
Liu, JT;Chen, CT;Lan, KKG;Tzeng, CS;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2016-07 |
Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA
|
Wang, WY;Lin, TY;Twu, CW;Tsou, HH;Lin, PJ;Liu, YC;Huang, JW;Hsieh, HY;Lin, JC |
| 國家衛生研究院 |
2016-07 |
GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer
|
Hsu, CP;Chuang, HC;Lee, MC;Tsou, HH;Lee, LW;Li, JP;Tan, TH |
| 國家衛生研究院 |
2016-06 |
Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials
|
Liu, JT;Tsou, HH;Gordon Lan, KK;Chen, CT;Lai, YH;Chang, WJ;Tzeng, CS;Hsiao, CF |
| 國家衛生研究院 |
2016-05-03 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Shen, YY;Chao, Y;Chen, MH;Yeh, TS;Shan, YS;Huang, SF;Chen, LT |
| 國家衛生研究院 |
2016-04-21 |
The discrete random-effects model-assessing benefit and consistency of treatment effect
|
Tsou, HH;Lan, KKG;Liu, JT;Hsiao, CF |
| 國家衛生研究院 |
2015-09-01 |
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients
|
Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C |
| 國家衛生研究院 |
2014-06 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL |
| 國家衛生研究院 |
2014-04 |
The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance
|
Wang, SC;Tsou, HH;Chung, RH;Chang, YS;Fang, CP;Chen, CH;Ho, IK;Kuo, HW;Liu, SC;Shih, YH;Wu, HY;Huang, BH;Lin, KM;Chen, AC;Hsiao, CF;Liu, YL |
| 國家衛生研究院 |
2014-04 |
Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis
|
Tsou, HH;Yang, HC;Chuang, MH;Wu, HY;Hsu, YT;Chang, WJ;Hsiao, CF;Hsu, C;Grp, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2014-01 |
Establishing non-inferiority of a new treatment in a three-arm trial: Apply a step-down hierarchical model in a papulopustular acne study and an oral prophylactic antibiotics study
|
Liu, JT;Tzeng, CS;Tsou, HH |
| 國家衛生研究院 |
2014-01 |
Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Chao, Y;Shan, YS;Huang, SF;Chiu, CF;Lee, KD;Chen, LT |
Showing items 36-60 of 109 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
